The Latin America, Middle East and Africa Guillain-Barre Syndrome Market would witness market growth of 6.2% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA Guillain-Barre Syndrome Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $15,320.9 Thousands by 2030. The Argentina market is registering a CAGR of 7.1% during (2023 - 2030). Additionally, The UAE market would showcase a CAGR of 5.9% during (2023 - 2030).
Cerebrospinal fluid (CSF) analysis lumbar puncture is performed to obtain CSF samples for analysis, including cell counts, protein levels, and the presence of inflammatory markers such as elevated protein levels without an increase in white blood cells, indicative of albumin cytologic dissociation, a hallmark of GBS.
Additionally, magnetic resonance imaging (MRI) of the spine and nerve roots may reveal characteristic findings such as nerve root enhancement, nerve enlargement, or spinal cord abnormalities, supporting the diagnosis of GBS and ruling out other neurological conditions.
The World Health Organization (WHO) reports that 130 suspected cases of GBS were reported in Peru between June 10, 2023, and July 15, 2023. 44 of these cases have been verified. The number of instances observed has increased more than anticipated. Additionally, 231 probable GBS cases were reported in Peru between epidemiological weeks 1 and 28 (until July 15, 2023). Thus, the rising aging population and increasing healthcare expenditure in the LAMEA region propel the market’s growth.
Free Valuable Insights: The Worldwide Guillain-Barre Syndrome Market is Projected to reach USD 852.2 Million by 2030, at a CAGR of 4.6%
Based on Therapeutics, the market is segmented into Intravenous Immunoglobulin, Plasma Exchange, and Others. Based on Route of Administration, the market is segmented into Parenteral, and Oral. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
By Therapeutics
By Route Of Administration
By Distribution Channel
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
